Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease.
Phytomedicine
; 70: 153208, 2020 Apr 15.
Article
em En
| MEDLINE
| ID: mdl-32283413
Palavras-chave
AAS, acetylsalicylic acid; AHA, the American Heart Association; Adjuvant therapy; C IVIG, intravenous immunoglobulin; CALs, coronary artery lesions; CASP, caspase; CD, cluster of differentiation; CRP, C-reactive protein; DAVID, Database for Annotation, Visualization and Integrated Discovery; Diagnostic marker; Epidemiology; FCGR2A, Fc fragment of immunoglobulin G, low-affinity IIa; GWAS, genome-wide association method; HAdV, the human adenovirus; Herbal chemicals; IL, Interleukin; ITPKC, inositol 1,4,5-triphosphate 3-kinase; KD, Kawasaki disease; Kawasaki disease; MyD88, myeloid differentiation factor 88; NF-κB, nuclear factor κB; RS, Reye's syndrome; SNPs, single nucleotide polymorphisms; Susceptibility genes; TCMs, traditional Chinese medicines; TLR4, toll-like receptor 4; TNF, tumor necrosis factor; Th, T helper
Texto completo:
1
Base de dados:
MEDLINE
Métodos Terapêuticos e Terapias MTCI:
Terapias_biologicas
Assunto principal:
Fitoterapia
/
Síndrome de Linfonodos Mucocutâneos
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Screening_studies
País/Região como assunto:
Asia
Idioma:
En
Revista:
Phytomedicine
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
China